(Press-News.org) LOS ANGELES — City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, today announced that internationally recognized physician-scientist Christine M. Lovly, M.D., Ph.D., F.A.S.C.O., will spearhead the development of its new national thoracic oncology program, furthering City of Hope’s mission to deliver exceptional multidisciplinary care and transformative research for patients with lung cancer. Dr. Lovly’s appointment is effective Jan. 1.
Dr. Lovly will be division chief of thoracic medical oncology, professor in the Department of Medical Oncology & Therapeutics Research at City of Hope National Medical Center and will hold the Dr. Norman and Melinda Payson Professorship in Medical Oncology.
She brings nearly two decades of experience in clinical care, translational research and academic leadership. She joins City of Hope at a critical time in the fight against lung cancer, as rates of the disease continue to rise — especially among women, younger people and nonsmokers.
Her pioneering work has shaped the modern landscape of lung cancer care, leading to more effective therapies tailored to the genetic makeup of individual tumors. Dr. Lovly is a leading authority on the molecular dynamics of targeted therapy response and resistance, especially in lung cancer subtypes characterized by EGFR and ALK alterations.
“Dr. Christine Lovly is a widely recognized expert whose groundbreaking research and unwavering commitment to patient-centered care make her an extraordinary addition to City of Hope. Her expertise in precision medicine and translational science will be instrumental in shaping our national thoracic oncology program and accelerating progress for patients with lung cancer across the country,” said Marcel van den Brink, M.D., Ph.D., president, City of Hope Los Angeles and City of Hope National Medical Center, and Deana and Steve Campbell Chief Physician Executive Distinguished Chair in Honor of Alexandra Levine, M.D.
Dr. Lovly will be responsible for advancing multidisciplinary clinical care, building and mentoring a world-class faculty, expanding translational and clinical research, and fostering strategic partnerships to further solidify City of Hope as a national leader in lung cancer innovation and patient outcomes. Dr. Lovly’s arrival marks an exciting chapter for City of Hope. Her collaborative, innovative approach will further elevate City of Hope’s lung cancer program and strengthen its systemwide commitment to excellence.
Her research portfolio includes ongoing projects focused on biomarkers, drug development and residual disease. She integrates data science into her research, helping create predictive algorithms to uncover potent drug interactions with the potential to improve efficacy and lessen side effects. This body of work resulted in Dr. Lovly receiving the 2025 William J. Darby Award “for translational research that has changed the practice of medicine worldwide.”
Today the LUNGevity Foundation presented Dr. Lovly with the Face of Hope Award, which is given to individuals who recognize the needs of those living with lung cancer and is actively making a difference on their behalf. Past recipients include Richard Pazdur, M.D., director of the U.S. Food and Drug Administration’s Oncology Center of Excellence, and Robert Winn, M.D., president of the Association of American Cancer Institutes.
“I believe the future of lung cancer care lies in precision medicine and team-based collaboration, and City of Hope is the ideal place to bring that vision to life,” Dr. Lovly said. “I look forward to working alongside world-class clinicians and researchers to build a program that truly serves patients and their families.”
Dr. Lovly comes to City of Hope from Vanderbilt University Medical Center, where she was a tenured faculty member and held a joint appointment at the Veterans Affairs Medical Center. She is an elected member of the American Society for Clinical Investigation and serves on numerous editorial boards, including Cancer Discovery, Clinical Cancer Research and JCO Precision Oncology. Dr. Lovly holds leadership roles in multiple national and international organizations, including as a current member of the American Association for Cancer Research (AACR) Board of Directors.
Dr. Lovly contributes to the scientific leadership boards of LUNGevity Foundation, GO2 Foundation for Lung Cancer Research and Lung Cancer Research Foundation. Additionally, she plays a key role in shaping national standards of care through her service on the National Comprehensive Cancer Network (NCCN) guidelines panel for non-small cell lung cancer.
# # #
About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the United States, and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation’s top cancer centers by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
END
Higher levels of greenness are associated with lower risks of hospital admissions for mental disorders, finds an analysis of data from seven countries over two decades, published in the BMJ’s climate issue today.
Local greenness was associated with a 7% reduction in hospital admissions for all cause mental disorders, with stronger associations for substance use disorders (9%), psychotic disorders (7%), and dementia (6%). However, associations varied across countries and disorders. For example, Brazil, Chile, and Thailand showed consistent ...
Lisbon, Portugal: Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast cancer according to new results presented at the Advanced Breast Cancer Eighth International Consensus Conference (ABC8) today (Friday).
Anne May, Professor of Clinical Epidemiology of Cancer Survivorship at the University Medical Center (UMC) Utrecht and the Netherlands Cancer Institute, The Netherlands, presented new results [1] from the PREFERABLE-EFFECT study [2] that showed a nine-month programme of supervised exercise improved muscle mass and muscle strength, particularly in the arms and ...
DETROIT – Researchers at Wayne State University will work with Michigan agencies and education partners to improve access to school-based substance use prevention and treatment programs for adolescents who are at risk of substance misuse and substance use disorders (SUDs).
The research will be funded by a two-year, $883,176 R61 exploratory grant from the National Institute on Drug Abuse of the National Institutes of Health. Dr. Andria B. Eisman, associate professor of community health in Wayne State’s College of Education, will lead the study, “Reducing Addiction through ...
Woodpeckers pack a punch., pounding wood with extreme force and experiencing decelerations of up to 400g. Now Nicholas Antonson, Matthew Fuxjager, Stephen Ogunbiyi, Margot Champigneulle and Thomas Roberts (all at Brown University, USA) and bird song expert Franz Goller (University of Münster, Germany) reveal in Journal of Experimental Biology that drilling woodpeckers turn themselves in hammers birds by bracing their head, neck, abdomen and tail muscles to hold their bodies rigid when they pound on wood, driving each impact with the hip flexor and front neck muscles.
In addition, ...
A team of four leading scientists from four European universities has been awarded a prestigious Synergy Grant of approximately €10 million by the European Research Council (ERC) for the project CARAMEL (Covalent Chaotropic Membrane Transport for Biotherapeutic Delivery). The project aims to overcome one of the biggest challenges in medicine: efficiently delivering modern biotherapeutics, such as peptides and proteins, into cells—a key hurdle in developing new treatments for diseases like cancer.
The CARAMEL project team comprises four principal investigators from leading European universities: Dr. ...
Jiahe Zhang, PhD, of the Department of Psychiatry at Mass General Brigham, is the lead author of the paper published in Nature Neuroscience, “Cortical and subcortical mapping of the human allostatic-interoceptive system using 7 Tesla fMRI.”
Lisa Feldman Barrett, PhD, and Marta Bianciardi, PhD, of the Department of Radiology at Mass General Brigham are co-senior authors. Barrett is also affiliated with the Department of Psychiatry at Mass General Brigham.
Q: How would you summarize your study for a lay audience?
Using an ultra-high-resolution imaging technology called 7 Tesla functional MRI (fMRI) on human participants, we mapped how different parts of the brain work together. ...
HOUSTON – (Nov. 6, 2025) – A team of researchers from Rice University and the Houston Methodist Research Institute has received a John S. Dunn Foundation Collaborative Research Award through the Gulf Coast Consortia to study how the brain responds over time to neural implants.
The project brings together expertise in materials science, neuroscience and clinical medicine and is led by Rice researchers Yimo Han, assistant professor of materials science and nanoengineering, and Chong Xie, associate professor of electrical and computer engineering, together with Dr. Damiano Barone, assistant professor in the Department of Neurosurgery at the Houston Methodist ...
NORMAN, Okla. – Lethal lettuce in Missouri. Murderous onions in Colorado. To biochemists at the University of Oklahoma, these aren’t just headlines – they’re warnings of the risks posed by drug-resistant bacteria and the human cost of inaction.
“Treatment of chronic conditions and many surgeries requires antibiotics,” said Helen Zgurskaya, George Lynn Cross Research Professor in the OU Department of Chemistry and Biochemistry. “When bacteria become resistant to antibiotics ...
The Ecological Society of America (ESA) presents a roundup of four research articles recently published across its esteemed journals. Widely recognized for fostering innovation and advancing ecological knowledge, ESA’s journals consistently feature illuminating and impactful studies. This compilation of papers explores unexpected links between Arctic land and sea, how much beavers could counter the threat of wildfire, whether uniformity within a species is good for biodiversity and what happened after ...
(MEMPHIS, Tenn. – November 6, 2025) The enzyme RNA polymerase II transcribes genes into messenger RNA. This process is guided by modifications to the enzyme’s “tail” called phosphorylation patterns. Scientists at St. Jude Children’s Research Hospital explored these patterns, identifying 117 kinases that could phosphorylate multiple locations within the protein tail. This greatly expands upon the set of kinases previously known to phosphorylate RNA polymerase II. The work also links the enzyme’s activity to ...
